The Eli and Edythe L. Broad Institute of MIT and Harvard (/ˈbroʊd/), often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and is partners with Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Shenzhen Yuanzheng Cell Medical Technology Co., Ltd., established on 2013-07-11, Business scope includes general business items:chemicals,natural medicine,New technology research and development application related to biotechnology products;Disinfection and sterilization products,hygiene products,Research and development of cosmetics;Basic research in biomedical technology;Bioengineering Technical Consulting,Economic Information Consulting;Business Management Consulting,Bioengineering technology projects and related technology transfer,technical consulting;Reagents for experiments and production,Consumables,equipment,Wholesale of instruments,Import and export and related supporting business(Commodities that do not involve state trade management.Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations).,The licensing program is:

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Tianjin Hengjia Biotechnology Development Co., Ltd., established on 2015-01-21, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Non-residential real estate leases;housing lease.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III Medical Device Leasing.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

Neoantigen is a high-tech and innovative enterprise specializing in the research and development of individualized tumor vaccines. It is committed to developing various individualized immunotherapy products based on neoantigens. The founder of the company proposed the concept of neoantigen-based therapy in China in 2005 and is one of the leaders in the research and development of neoantigen-related products in the world.

Nanjing Gulou Hospital is a Chinese private company located in Nanjing. The firm operates as a hospital.

Mnemo Therapeutics SAS is a company headquartered in Paris, France, with operations in the United States, that develops cell therapies that create accessible cures for solid tumors and blood cancers. It was founded in 2019 by Alain Maïore and Michel Sadelain. Robert LaCaze has been the CEO since 2022.\nThe company says this about itself: Mnemo is driven to create powerful immunotherapies to improve the body's ability to detect and eradicate cancer. A lack of cancer-specific targets, coupled with lack of long-term persistence and sensitivity, create significant challenges in the field of immuno-oncology. Mnemo is committed to addressing these problems and engineering the future of immunotherapies to transform the lives of people with cancer through the discovery of novel cancer-specific targets, while boosting immune activity to treat solid tumors. Mnemo is headquartered in Paris and maintains state of the art laboratories in Paris, New York, and Princeton, New Jersey.

Hengruiyuanzheng (Shanghai) Biotechnology Co., Ltd., established on 2015-07-08, Business scope includes licensed projects:pharmaceutical production;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:working in medical technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,Engaged in the import and export of goods and technology,Re-export trade,Trade and trade agency between enterprises in the region,First,Class II medical device,electronic product,Equipment,Sales of metal materials and products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Suzhou Lanma Medical Technology Co., Ltd., established on 2020-12-16, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class I Medical Devices;Sales of Class II Medical Devices;business management;Instrument sales;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Cancer Research Ventures Ltd. engages in the business of research and experimental development on biotechnology. It provides medical products. The company is headquartered in London, the United Kingdom.

Centre Hospitalier Universitaire Vaudois (doing business as Lausanne University Hospital) is a private company headquartered in Lausanne, Switzerland, that operates university hospitals.\nThe company says this about itself: The CHUV, Lausanne University Hospital, is one of the five university hospitals in Switzerland. With its 16 clinical and medico-technical departments and their numerous services, the CHUV is renowned for its academic achievements in health care, research, and teaching. The CHUV is also a well-known center of medical education and research thanks to its collaboration with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). The CHUV has been recognized as one of the World?s 10 best hospitals according to the 2021 ranking of Newsweek magazine. It is with enthusiasm, that the Chairman of the Department of Urology, Prof Beat Roth, will pursue and support the research and studies with this novel treatment for bladder cancer.

Guangzhou Saibaiao Biomedical Technology Co., Ltd., established on 2020-02-26, Business scope includes drug research and development;Pharmaceutical Research Services;Medical technology research and development;Gene drug development;Research and development of biological products(Does not include licensed operations);Biological Products Testing;Sales of Biological Products(Does not include licensed operations);Research and development of biodiagnostic reagents and kits(Does not include license approval items);Biotechnology Extension Services;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Biomedical Technology Research;Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Operation of non-licensed medical devices;Medical supplies and equipment retail(Does not contain drugs and medical devices);for medical devices,equipment,Professional cleaning of medical and sanitary materials and supplies,Disinfection and Sterilization;Biopharmaceutical Manufacturing;Internet drug transaction service;Drug retail;Preparation of cell preparations and related products;Sales of cell preparations and related products;Collection of immune cells,storage,preparation service(Without umbilical cord blood hematopoietic stem cell collection,storage);Genetic testing and disease screening services;Health food manufacturing;Health food wholesale(Specific business items are<food business license>prevail);Health Food Retail(Specific business items are<food business license>prevail);Manufacturing of chemical raw materials;Production of Chinese herbal extracts(The specific business items are subject to the drug production license);Manufacture of stem cell series technical engineering products;Manufacture of stem cell engineering series products;Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail);Licensed medical device business;Provide medical device storage and distribution services;

NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.

Shenzhen Yutai Antigen Technology Co., Ltd., established on 2018-06-29, Business scope includes general business items:Engaged in technical promotion services in the field of life sciences and biotechnology;working in medical technology,Detection Technology,Biological Technology,computer technology,Technology development in the field of data technology specialization,technical consulting,Technical Services,technology transfer;Business Management Consulting;Bioengineering technology projects and related technology transfer,technical consulting;Reagents for experiments and production,Consumables,equipment,Wholesale of instruments,Import and export and related supporting business;Instrumentation,Laboratory Equipment Sales,computer,Software and auxiliary equipment sales;Immunotherapy Tumor Biomarkers,Screening and Identification of Tumor Antigens;Basic and clinical research in biomedical technology.(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:Medical Research and Experimental Development;Clinical Laboratory Services;one,two,Wholesale and sales of Class III medical devices;Health Advisory(Do not engage in medical activities,psychological counseling).

Theragen Bio offers a software platform for NGS and genome and transcriptome analysis. The business offers next-generation sequencing equipment like the NovaSeq 6000, HiSeq 4000, Ion S5 XL, Ion proton, Ion PGM, and MiSeqDx. The company uses QuanStudio, Fludigm, BeadXpress, GeneTitan, and LC480 as its genotyping platforms. It provides services for research, diagnostics, and healthcare.